The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Untreated Adult Acute Myeloid Leukemia

Added text about a randomized trial that assigned low-risk patients to receive all-trans-retinoic acid and daunorubicin as induction therapy, followed by daunorubicin consolidation and ATRA plus mercaptopurine plus methtrexate as maintenance therapy (cited Adès et al. as reference 36 and level of evidence 3iiiA).

Back to Top

< Previous Section  |  Next Section >